Clinical trial
Olanzapine in Standard Clinical Practice. 6-month Efficacy and Safety Monitoring
NCT02006862 is registered in ClinicalTrials.gov with Elpen Pharmaceutical Co. Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Olanzapine in Standard Clinical Practice. 6-month Efficacy and Safety Monitoring
- Lead sponsor
- Elpen Pharmaceutical Co. Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- December 31, 2014
- Enrollment
- 468 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.